Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

1.

Chemoimmunotherapy for advanced gastrointestinal carcinomas: A successful combination of gene therapy and cyclophosphamide.

Malvicini M, Piccioni F, Bayo J, Fiore E, Atorrasagasti C, Alaniz L, Garcia M, Aquino JB, Gidekel M, Matar P, Mazzolini G.

Oncoimmunology. 2012 Dec 1;1(9):1626-1628.

PMID:
23264916
[PubMed]
Free PMC Article
2.

Reversal of gastrointestinal carcinoma-induced immunosuppression and induction of antitumoural immunity by a combination of cyclophosphamide and gene transfer of IL-12.

Malvicini M, Ingolotti M, Piccioni F, Garcia M, Bayo J, Atorrasagasti C, Alaniz L, Aquino JB, Espinoza JA, Gidekel M, Scharovsky OG, Matar P, Mazzolini G.

Mol Oncol. 2011 Jun;5(3):242-55. doi: 10.1016/j.molonc.2011.03.007. Epub 2011 Apr 5.

PMID:
21515097
[PubMed - indexed for MEDLINE]
Free Article
3.

Single low-dose cyclophosphamide combined with interleukin-12 gene therapy is superior to a metronomic schedule in inducing immunity against colorectal carcinoma in mice.

Malvicini M, Alaniz L, Bayo J, Garcia M, Piccioni F, Fiore E, Atorrasagasti C, Aquino JB, Matar P, Mazzolini G.

Oncoimmunology. 2012 Oct 1;1(7):1038-1047.

PMID:
23170252
[PubMed]
Free PMC Article
4.

A novel synergistic combination of cyclophosphamide and gene transfer of interleukin-12 eradicates colorectal carcinoma in mice.

Malvicini M, Rizzo M, Alaniz L, Piñero F, García M, Atorrasagasti C, Aquino JB, Rozados V, Scharovsky OG, Matar P, Mazzolini G.

Clin Cancer Res. 2009 Dec 1;15(23):7256-65. doi: 10.1158/1078-0432.CCR-09-1861. Epub 2009 Nov 17.

PMID:
19920110
[PubMed - indexed for MEDLINE]
Free Article
5.

[Antitumor effect of combined therapy with adenovirus-mediated CD suicide gene and interleukin 2 gene transfer and its immunological mechanism].

Ju D, Cao X, Wang B.

Zhonghua Zhong Liu Za Zhi. 1998 Mar;20(2):108-11. Chinese.

PMID:
10920957
[PubMed - indexed for MEDLINE]
6.
7.

Adoptive transfer of anti-CD3-activated CD4+ T cells plus cyclophosphamide and liposome-encapsulated interleukin-2 cure murine MC-38 and 3LL tumors and establish tumor-specific immunity.

Saxton ML, Longo DL, Wetzel HE, Tribble H, Alvord WG, Kwak LW, Leonard AS, Ullmann CD, Curti BD, Ochoa AC.

Blood. 1997 Apr 1;89(7):2529-36.

PMID:
9116299
[PubMed - indexed for MEDLINE]
Free Article
8.

A metronomic schedule of cyclophosphamide combined with PEGylated liposomal doxorubicin has a highly antitumor effect in an experimental pulmonary metastatic mouse model.

Shiraga E, Barichello JM, Ishida T, Kiwada H.

Int J Pharm. 2008 Apr 2;353(1-2):65-73. Epub 2007 Nov 17.

PMID:
18155369
[PubMed - indexed for MEDLINE]
9.

Pre-existing tumor-sensitized T cells are essential for eradication of established tumors by IL-12 and cyclophosphamide plus IL-12.

Le HN, Lee NC, Tsung K, Norton JA.

J Immunol. 2001 Dec 15;167(12):6765-72.

PMID:
11739491
[PubMed - indexed for MEDLINE]
Free Article
10.

Chemo-immunotherapy of murine solid tumors: enhanced therapeutic effects by interleukin-2 combined with interferon alpha and the role of specific T cells.

Kedar E, Rutkowski Y, Leshem B.

Cancer Immunol Immunother. 1992;35(1):63-8.

PMID:
1611625
[PubMed - indexed for MEDLINE]
11.

Intensification of antitumor effect by T helper 1-dominant adoptive immunogene therapy for advanced orthotopic colon cancer.

Nakamori M, Iwahashi M, Nakamura M, Ueda K, Zhang X, Yamaue H.

Clin Cancer Res. 2003 Jun;9(6):2357-65.

PMID:
12796406
[PubMed - indexed for MEDLINE]
Free Article
12.

Adoptively transferred ex vivo activated memory T cells with cyclophosphamide: effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma.

Gold JE, Zachary DT, Osband ME.

Clin Immunol Immunopathol. 1994 Oct;73(1):115-22. Erratum in: Clin Immunol Immunopathol 1995 Jul;76(1 Pt 1):105. Retraction in: Clin Immunol Immunopathol. 1998 Jun;87(3):314.

PMID:
7923908
[PubMed - indexed for MEDLINE]
13.

Enhanced antitumor immune responses of IL-2 gene-modified tumor vaccine by combination with IL-1 and low dose cyclophosphamide.

Cao X, Zhang W, Wan T, Yu Y, Tao Q, Wang J.

J Exp Clin Cancer Res. 1999 Jun;18(2):173-9.

PMID:
10464704
[PubMed - indexed for MEDLINE]
14.
16.

Interleukin-18 gene transfer increases antitumor effects of suicide gene therapy through efficient induction of antitumor immunity.

Ju DW, Yang Y, Tao Q, Song WG, He L, Chen G, Gu S, Ting CC, Cao X.

Gene Ther. 2000 Oct;7(19):1672-9.

PMID:
11083476
[PubMed - indexed for MEDLINE]
Free Article
17.

Tumor-specific chemoimmunotherapy of murine fibrosarcoma using tumor-specific transplantation antigen, cyclophosphamide, and interleukin-2.

Naito K, Nomi S, Komichi H, Ueda Y, Yamagishi H, Oka T, Pellis NR, Kahan BD.

Cancer Detect Prev. 1992;16(5-6):321-7.

PMID:
1361881
[PubMed - indexed for MEDLINE]
18.

Adenovirus-mediated combined suicide gene and interleukin-2 gene therapy for the treatment of established tumor and induction of antitumor immunity.

Ju DW, Wang BM, Cao X.

J Cancer Res Clin Oncol. 1998;124(12):683-9.

PMID:
9879829
[PubMed - indexed for MEDLINE]
19.

Combination therapy with interleukin-2 and wild-type p53 expressed by adenoviral vectors potentiates tumor regression in a murine model of breast cancer.

Pützer BM, Bramson JL, Addison CL, Hitt M, Siegel PM, Muller WJ, Graham FL.

Hum Gene Ther. 1998 Mar 20;9(5):707-18.

PMID:
9551618
[PubMed - indexed for MEDLINE]
20.

Intratumoral administration of adenoviral interleukin 7 gene-modified dendritic cells augments specific antitumor immunity and achieves tumor eradication.

Miller PW, Sharma S, Stolina M, Butterfield LH, Luo J, Lin Y, Dohadwala M, Batra RK, Wu L, Economou JS, Dubinett SM.

Hum Gene Ther. 2000 Jan 1;11(1):53-65.

PMID:
10646639
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk